Active Ingredient: BENDROFLUMETHIAZIDE; NADOLOL
Proprietary Name: CORZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018647
Product Number: 001
Approval Date: May 25, 1983
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information